From:  GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis

Forest plot and pooled estimates of the effect of GLP-1 RAs on changes in serum aspartate aminotransferase (AST) levels of in the eligible RCTs (n = 6). The effect size was expressed as WMD and 95% CIs